Lindenwold Advisors’s Repligen RGEN Stock Holding History

Lindenwold Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,109	Closed	-$209K	–	120
2022 Q1	$209K	Buy	1,109 +210	+23%	+$39.9K	0.13%	120
2021 Q4	$238K	Buy	+899	New	+$242K	0.14%	119

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lindenwold Advisors's RGEN Position: Q2 2022 in Review

Lindenwold Advisors sold out of Repligen (RGEN) in Q2 2022, closing a stake of 1,109 shares — an estimated $209K sold.

Lindenwold Advisors first reported a position in RGEN in Q4 2021 and held it in 2 quarters. The position peaked at $238K in Q4 2021. 404 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

Lindenwold Advisors reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
Lindenwold Advisors sold 1,109 Repligen shares in Q2 2022, an estimated $209K.
Lindenwold Advisors first reported a position in Repligen in Q4 2021 and held it in 2 quarters.
Lindenwold Advisors's Repligen position peaked at $238K in Q4 2021.
404 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Lindenwold Advisors's 13F filing for Q2 2022, filed 5 Aug 2022.